Displaying 13 - 24 of 32
Metabolism, Alcohol & Toxicity

Essential phospholipids in the liver health landscape – clinical evidence

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD – the importance of early identification and interventio

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD-associated metabolic risks in obesity and diabetes – insights from clinical practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A and panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Viral Hepatitis

Introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from an HCP perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How can we face itch in the present?

Webcasts
View
Viral Hepatitis

Benefits and barriers to achieving functional cure

Webcasts
View
Viral Hepatitis

The importance of quantitative hepatitis B surface antigen in achieving functional cure: A clinical perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from a patient perspective?

Webcasts
View
Displaying 13 - 24 of 32